Dr. Akhtar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
53960 Van Dyke Ave
Shelby Township, MI 48316Phone+1 586-323-1500Fax+1 586-323-1515
Summary
- Dr. Adil Akhtar is currently Chief, Division of Palliative & End of Life Care, Michigan Health Professionals, and Director, Inpatient Clinical Services, Karmanos-McLaren Oakland Cancer Center in Michigan. In addition, he is Associate Professor, Department of Medical Oncology & Hematology, Oakland University-William Beaumont School of Medicine. He is President and CEO of Advance Care Now, LLC. He is also the Medical Director of Premier Hospice and Palliative care. Dr. Akhtar’s medical specializations are oncology, palliative care and end of life/hospice care.
Dr. Adil Akhtar believes that everyone has a right to decide what kind of medical care they want. He is very passionate about the healthcare living will and advance care planning. He has founded Advance Care Now to help people understand and make decisions about advance care planning.
Dr. Akhtar received his M.B., B.S. at Dow Medical College, University of Karachi, Pakistan. His training includes a Research Fellowship in Experimental Hematopoiesis, Department of Oncology, Johns Hopkins University in Baltimore; a Clinical Fellowship in the Division of Oncology, Department of Medicine, Wayne State University in Detroit; and his Residency was at Wayne State University School of Medicine, Internal Medicine, Division of Hematology and Oncology in Detroit.
Dr. Akhtar also specializes in palliative care, the holistic multidisciplinary medical care for people with serious illness. This type of care is focused on providing relief from the physical symptoms and emotional stress of a serious illness. The goal is to improve quality of life for both the patient and the family. From pain management, emotional support to proper diet and nutrition. Palliative care can be implemented in conjunction with the cancer treatment such as radiation therapy and chemotherapy. Dr. Akhtar’s program is a pioneer in home based palliative care.
Education & Training
- Berkeley University Chief Executive Officer Program, 2023 - 2024
- Harvard University Master in Clinical Service Operations MCSO, 2021 - 2023
- Harvard UniversityEffective Writing class of 2021, Healthcare writing, 2020 - 2021
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1994 - 1995
- Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 1992 - 1994
- Wayne State University School of MedicineResidency, Internal Medicine, 1989 - 1992
- Dow University of Health SciencesClass of 1986
Certifications & Licensure
- MI State Medical License 1996 - 2027
- CA State Medical License 2020 - 2022
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Hour Detroit Top Doctor Hour Magazine, 2018
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 3 citationsMultidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma.Kevin C Flanagan, Jon Earls, Ian Schillebeeckx, Jeffrey Hiken, Rachel L Wellinghoff
Journal of Cancer Research and Clinical Oncology. 2023-11-01 - 304 citationsBCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agentsAtul Bedi, James Barber, Gauri C. Bedi, Wafik S. El-Deiry, David Sidransky
Blood. 1995-08-01 - 183 citationsInhibition of Spontaneous Metastasis in a Rat Prostate Cancer Model by Oral Administration of Modified Citrus PectinKenneth J. Pienta, Harmesh Nailk, Adil Akhtar, K. Yamazaki, Tracy S. Replogle
Journal of the National Cancer Institute. 1995-03-01
Authored Content
- Erdafitinib, the First-Ever Targeted Therapy for Bladder Cancer, Receives Accelerated FDA ApprovalJuly 2019
- Achieving "Victory" Through Holistic Palliative CareJuly 2019
- Achieving “Victory” Through Holistic Palliative CareJuly 2019
- HANDLING A DIFFICULT DISCUSSIONJune 2019
- When it comes to improving hospice care, timing is everythingMarch 2019
- When it comes to improving hospice care, timing is everythingMarch 2019
- When it comes to improving hospice care, timing is everythingMarch 2019
- Join now to see all
Press Mentions
- The Best Foods for Healthy Lungs—and the Ones You Should AvoidOctober 17th, 2022
- 19 Silent Lung Cancer Symptoms You Need to Be Aware OfNovember 7th, 2019
- The Best Foods for Healthy Lungs—and the Ones to AvoidAugust 1st, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: